David Kerr

DMC Biostatistician Director

David Kerr is a DMC Biostatistician Director at Cytel. He has dedicated 30 years to Axio Research, a Cytel company. David is a leader in Axio’s DMC services, which facilitate more than 500 DMC meetings annually. He played an instrumental role in developing SOPs that govern Axio’s DMC services. In addition to his duties as DMC Biostatistician Director, David has provided statistical support as the reporting statistician for more than 250 DMCs covering 300 individual clinical trials. His expertise spans disease areas such as oncology, cardiology, infectious disease, respiratory disease, and rheumatology. He has attended over 1000 DMC meetings, becoming a strong advocate for improving DMC processes. He regularly presents at conferences and conducts industry tutorials to ensure DMCs are equipped with the best information to make educated recommendations, prioritizing both trial success and participant safety.

David received his Master’s in Statistics from the University of Washington and is based in Seattle, Washington.